Michael F. Romero
Papers
2
Total Citations
7
H-Index
2
About
Michael F. Romero’s research centers on advancing noninvasive imaging techniques for preclinical kidney disease, with a particular focus on polycystic kidney disease (PKD). His major contributions lie in validating and comparing robotic 3D ultrasound with magnetic resonance imaging (MRI) for assessing renal pathology in rodent models. In his most cited work (2020, 5 citations), Romero demonstrated that robotic 3D ultrasound can reliably measure total kidney volume (TKV)—a key biomarker for staging PKD severity—offering a more accessible, cost-effective alternative to MRI without sacrificing accuracy. His subsequent study (2021, 2 citations) further refined this approach, highlighting the practical advantages of robotic ultrasound over other imaging modalities like PET and CT, including lower cost, ease of use, and absence of ionizing radiation. By bridging the gap between high-resolution imaging and routine preclinical screening, Romero’s work has significant implications for accelerating drug discovery and reducing animal use in longitudinal studies. His findings support the adoption of robotic ultrasound as a standard tool in nephrology research, making kidney disease assessment faster, safer, and more reproducible.
Research Focus
Key Achievements
Top Papers
- 1
- 2